| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5531198 | Cytokine & Growth Factor Reviews | 2017 | 5 Pages |
Abstract
â¢Immunotherapy strategies of HCC have not been successful until now.â¢The current ongoing EU-funded HEPAVAC project is developing a new concept of therapeutic cancer vaccine for HCC, aiming at addressing the weak points of the previous attemps.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Luigi Buonaguro, the HEPAVAC Consortium the HEPAVAC Consortium,